Cargando…

Antiplatelet agents aspirin and dipyridamole, and the risk of different carcinoma in patients with type 2 diabetes mellitus: A Taiwan retrospective cohort study

Studies have shown aspirin decreases the risk of some cancers. However, the evidence reported the association between aspirin and cancer risk in the diabetic population. In this study, we investigate whether aspirin and dipyridamole decrease the risk of cancer in patients with type 2 diabetes. A tot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Hsing-Yi, Lu, Tz-Wen, Liang, Hsiu-Ling, Hsu, Wei-Hao, Sung, Ya-Wen, Lee, Mei-Yueh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478216/ https://www.ncbi.nlm.nih.gov/pubmed/36123870 http://dx.doi.org/10.1097/MD.0000000000030468

Ejemplares similares

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
por: Bath, Philip M, et al.
Publicado: (2018)

A Randomised Controlled Trial of Triple Antiplatelet Therapy (Aspirin, Clopidogrel and Dipyridamole) in the Secondary Prevention of Stroke: Safety, Tolerability and Feasibility
por: Sprigg, Nikola, et al.
Publicado: (2008)

Dipyridamole with Low-Dose Aspirin Augments the Infarct Size-Limiting Effects of Simvastatin
por: Ye, Yumei, et al.
Publicado: (2011)

Comparative evaluation of treatment with low-dose aspirin plus dipyridamole versus aspirin only in patients with acute ischaemic stroke
por: Arnarsdottir, Lola, et al.
Publicado: (2012)

Aspirin and antiplatelet treatments in cancer
por: Tao, Derrick L., et al.
Publicado: (2021)

Dipeptidyl Peptidase 4 Inhibitors Decrease the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Infection and Type 2 Diabetes Mellitus: A Nationwide Study in Taiwan
por: Hsu, Wei-Hao, et al.
Publicado: (2021)

Mechanisms of the antiplatelet and analgesic effects of dextromethorphan and its metabolites
por: Su, Wen-Lin, et al.
Publicado: (2019)

The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study
por: Wang, Mei-Tzu, et al.
Publicado: (2018)

Aspirin vs Clopidogrel: Antiplatelet Agent of Choice for Those With Recent Bleeding or at Risk for Gastrointestinal Bleed
por: Gosavi, Siddharth, et al.
Publicado: (2023)

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
por: Neubauer, Horst, et al.
Publicado: (2011)

Combination Therapy with Dipyridamole and Clopidogrel for Secondary Stroke Prevention in Aspirin-Intolerant Patients After Myocardial Infarction: Results of a Nationwide Case-Control Study
por: Wang, Mei-Tzu, et al.
Publicado: (2019)

Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
por: Hemlata,, et al.
Publicado: (2013)

Dissolvable polymeric microneedles loaded with aspirin for antiplatelet aggregation
por: Wang, Baorui, et al.
Publicado: (2023)

Dipyridamole ameliorates doxorubicin-induced cardiotoxicity
por: Alyasiry, Esraa, et al.
Publicado: (2022)

Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin
por: Kim, Joon-Tae, et al.
Publicado: (2020)

Aspirin use in central retinal arterial occlusion to prevent ischaemic stroke: a retrospective cohort study in Taiwan
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2019)

ICU service in Taiwan
por: Cheng, Kuo-Chen, et al.
Publicado: (2014)

Mean Daily Dosage of Aspirin and the Risk of Incident Alzheimer's Dementia in Patients with Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study in Taiwan
por: Chang, Cheng-Wei, et al.
Publicado: (2016)

Efficacy of aspirin, clopidogrel, and ticlopidine in stroke prevention: A population-based case-cohort study in Taiwan
por: Wong, Yi-Sin, et al.
Publicado: (2020)

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease
por: Pi, Lei, et al.
Publicado: (2018)

Perioperative management and monitoring of antiplatelet agents: a focused review on aspirin and P2Y(12) inhibitors
por: Mazzeffi, Michael A., et al.
Publicado: (2017)

Dipyridamole and vascular healing following stent implantation
por: Simard, Trevor, et al.
Publicado: (2023)

Effect of low dose aspirin and dipyridamole on primary patency of arteriovenous grafts in hemodialysis patients: a randomized double-blind placebo-controlled trial
por: Tayebi, Pouya, et al.
Publicado: (2018)

Optimal use of antiplatelet agents, especially aspirin, in the perioperative management of colorectal cancer patients undergoing laparoscopic colorectal resection
por: Yoshimoto, Yasunori, et al.
Publicado: (2019)

Celecoxib Does Not Attenuate the Antiplatelet Effects of Aspirin and Clopidogrel in Healthy Volunteers
por: Lee, Wonjae, et al.
Publicado: (2010)

Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
por: Khan, Hamzah, et al.
Publicado: (2020)

Comparative Efficacy and Safety of P2Y12 Inhibitor Monotherapy and Dual Antiplatelet Therapy in Patients with and without Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
por: Feng, Wen-Han, et al.
Publicado: (2022)

Potentiation of Some Anticancer Agents by Dipyridamole against Drug‐sensitive and Drug‐resistant Cancer Cell Lines
por: Asoh, Kuni‐ichi, et al.
Publicado: (1989)

Endoplasmic Reticulum Stress Contributed to Dipyridamole-Induced Impaired Autophagic Flux and Glioma Apoptosis
por: Chang, Cheng-Yi, et al.
Publicado: (2022)

Regadenoson is a better myocardial vasodilator than dipyridamole in normal volunteers, but the data is less compelling in patients
por: Vasu, Sujethra, et al.
Publicado: (2011)

Dipyridamole augments the antiinflammatory response during human endotoxemia
por: Ramakers, Bart P, et al.
Publicado: (2011)

The signal pathway for the repressive effect of dipyridamole on myofibroblast transdifferentiation
por: Yan, Qiong, et al.
Publicado: (2018)

Dipyridamole-induced STEMI: case report and review of the literature
por: Hennawi, Hussam Al, et al.
Publicado: (2023)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Qu, Jianyu, et al.
Publicado: (2021)

Continuity and Completeness of Electronic Health Record Data for Patients Treated With Oral Hypoglycemic Agents: Findings From Healthcare Delivery Systems in Taiwan
por: Hsu, Chien-Ning, et al.
Publicado: (2022)

Risk of skin cancer in patients with diabetes mellitus: A nationwide retrospective cohort study in Taiwan
por: Tseng, Hui-Wen, et al.
Publicado: (2016)

Do Aspirin and Other Antiplatelet Drugs Reduce the Mortality in Critically Ill Patients?
por: Lösche, Wolfgang, et al.
Publicado: (2012)

Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease
por: Larsen, Sanne Bøjet, et al.
Publicado: (2015)

Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel
por: Cirillo, Plinio, et al.
Publicado: (2020)

Lower Antiplatelet Effect of Aspirin in Essential Thrombocythemia than in Coronary Artery Disease
por: Pedersen, Oliver Buchhave, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ti0e2904rooisr3gjjq3e172i2